Modular Medical (MODD) EBITDA (2011 - 2025)

Modular Medical has reported EBITDA for 9 years, with the latest figure at -$7.2 million in Q4 2025.

• For the quarter ending Q4 2025, EBITDA fell 49.24% year-over-year to -$7.2 million; the trailing twelve-month figure through Dec 2025 stood at -$26.9 million (down 46.04% YoY), and the FY2025 full-year result was -$19.0 million, down 8.67% from the prior year.
• EBITDA for Q4 2025 stood at -$7.2 million, up from -$7.8 million in the prior quarter.
• The five-year high for EBITDA was -$1.7 million in Q1 2021, with the low at -$7.8 million in Q3 2025.
• Historically, EBITDA has averaged -$4.4 million across 5 years, with a median of -$4.1 million in 2022.
• The largest YoY upside for EBITDA was 12.35% in 2022 against a maximum downside of 132.42% in 2022.
• Modular Medical's EBITDA stood at -$3.8 million in 2021, then climbed by 12.35% to -$3.4 million in 2022, then sank by 56.91% to -$5.3 million in 2023, then climbed by 7.88% to -$4.9 million in 2024, then sank by 49.24% to -$7.2 million in 2025.
• The last three EBITDA figures came in at -$7.2 million (Q4 2025), -$7.8 million (Q3 2025), and -$6.8 million (Q2 2025), per Business Quant data.